NCT01756677: Low Dose Cytarabine and Lintuzumab-Ac225 in Older Patients |
|
|
| Active, not recruiting | 1/2 | 24 | US | Cytarabine, Cytosar, Ara-C, DepoCyt, Cytosine arabinosine hydrochloride, Low dose Ara-C, LDAC, Lintuzumab-Ac225, Lintuzumab, Lasix, furosemide, Spironolactone | M.D. Anderson Cancer Center, Actinium Pharmaceuticals | Leukemia | 10/16 | | | |